online ISSN 2415-3176
print ISSN 1609-6371
logoExperimental and Clinical Physiology and Biochemistry
  • 9 of 10
ECPB 2017, 79(3): 50–53

A Role of MicroRNAs in Pathogenesis of Renal Cell Carcinoma


Renal cell carcinoma (RCC) is an oncologic pathology that is found in 3 % of all cases of malignant tumors in adults and approximately in 90 % of malignant kidney lesions. Part of the MicroRNAs (miRNA, miR) in development of RCC is actively investigated. MiRNAs are small non-coding RNAs that regulate the expression of a broad gene spectrum by the means of impact on the 3′-untranslated regions (3′-UTR) of complementary mRNAs. MicroRNAs play the key part in such essential RCC development processes as cell growth and cell cycle regulation, apoptosis, replicative potential, angiogenesis, tissue invasion and metastasizing.

The purpose of this literature review is to analyze up-to-date data on role of microRNAs in pathogenesis of RCC.

Materials and methods. The systematic review of the available scientific literature using on-line scientific database PubMed and such keywords as ″renal cell carcinoma″, ″pathogenesis″, ″microRNA″, ″miRNA″ and ″miR″ has been performed.

Results and discussion. As a result of the database search using specified keywords 485 scientific papers have been found. The most relevant results have been selected for the literature review. The mechanism of RCC pathogenesis is complicated and continues to be unclear.

Large amount of investigations of miRNA in patients with RCC has been performed where the expression levels in tissues, blood, and urine have been measured and compared with those in healthy controls. A great number of explorations has showed that both overexpression and underexpression of miRNAs are characteristic for RCC. The mRNAs that seemed to play most important role in RCC pathogenesis are miR-1, miR-20b-5p, miR-22, miR-23b, miR-30c, miR-30d, miR-34a, miR-99a, miR-133a, miR-133b, miR-135a, miR-138, miR-143, miR-145, miR-182-5p, miR-199a-3p, miR-200c, miR-490-5p, miR-509-5p, miR-708, miR-1826 and have an impact on such mechanisms as cell cycle, migration, proliferation, invasion, modulation of the differentiation of mesenchymal stem cells.

Conclusion: there is a strong evidence of the important role of miRs in pathogenesis of RCC, however, further investigations are required in order to achieve more profound understanding of genetic mechanisms of development of this pathology.

Article recieved: 30.08.2017

Keywords: renal cell carcinoma, pathogenesis, microRNA, miRNA, miR

Full text: PDF (Eng) 781K

  1. 1. Banumathy Gowrishankar, Paul Cairns. "Signaling Pathways in Renal Cell Carcinoma." Cancer Biology & Therapy 10, no. 7 (October 1, 2010): 658-64.
  2. 2. Bera Amit, Falguni Das, Nandini Ghosh-Choudhury, Balakuntalam S. Kasinath, Hanna E. Abboud, and Goutam Ghosh Choudhury. "microRNA-21-Induced Dissociation of PDCD4 from Rictor Contributes to Akt-IKKβ-mTORC1 Axis to Regulate Renal Cancer Cell Invasion." Experimental Cell Research 328, no. 1 (October 15, 2014): 99-117.
  3. 3. Bera Amit, Nandini Ghosh-Choudhury, Nirmalya Dey, Falguni Das, Balakuntalam S. Kasinath, Hanna E. Abboud, and Goutam Ghosh Choudhury. "NFκB-Mediated Cyclin D1 Expression by microRNA-21 Influences Renal Cancer Cell Proliferation." Cellular Signalling 25, no. 12 (December 2013): 2575–86.
  4. 4. Croce C. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
  5. 5. Cui Li, Hua Zhou, Hu Zhao, Yaojun Zhou, Renfang Xu, Xianlin Xu et al. "MicroRNA-99a Induces G1-Phase Cell Cycle Arrest and Suppresses Tumorigenicity in Renal Cell Carcinoma." BMC Cancer 12 (November 23, 2012): 546.
  6. 6. Dey Nirmalya, Falguni Das, Nandini Ghosh-Choudhury, Chandi Charan Mandal, Dipen J. Parekh, Karen Block, Balakuntalam S. Kasinath, Hanna E. Abboud, and Goutam Ghosh Choudhury. "microRNA-21 Governs TORC1 Activation in Renal Cancer Cell Proliferation and Invasion." PloS One 7, no. 6 (2012): e37366.
  7. 7. Hao Bo, Li Cui, Yi Gu, Bo Zhang, Min Wang, Hua Zhou et al. "MiR-99A Suppresses Proliferation, Migration, Invasion and Induces G1-Phase Cell Cycle Arrest via Targeting IGF-1R Pathway in Renal Cell Carcinoma 786-0 and OS-RC-2 Cells." Urology 0, no. 0 (January 13, 2017).
  8. 8. He Jimin, Xiaoxin Guo, Linlin Sun, Kuhao Wang, and Haiying Yao. "Networks Analysis of Genes and microRNAs in Human Wilms' Tumors." Oncology Letters 12, no. 5 (November 2016): 3579-85.
  9. 9. Howlader N, Noone A, Krapcho M et al. SEER Cancer Statistics Review 1975-2016 / National Cancer Institute. Bethesda, MD., 2016.
  10. 10. Huang Jiwei, BaiJun Dong, Jin Zhang, Wen Kong, Yonghui Chen, Wei Xue, Dongming Liu, and Yiran Huang. "miR-199a-3p Inhibits Hepatocyte Growth Factor/C-Met Signaling in Renal Cancer Carcinoma." Tumor Biology 35, no. 6 (June 1, 2014): 5833–43.
  11. 11. Li Songchao, Tieding Chen, Zhaohui Zhong, Yi Wang, Yangle Li, and Xiaokun Zhao. "microRNA-155 Silencing Inhibits Proliferation and Migration and Induces Apoptosis by Upregulating BACH1 in Renal Cancer Cells." Molecular Medicine Reports 5, no. 4 (April 2012): 949–54.
  12. 12. Lichner Zsuzsanna, Salvador Mejia-Guerrero, Monika Ignacak, Adriana Krizova, Tian Tian Bao, Andrew H. F. Girgis, Yousef M. Youssef, and George M. Yousef. "Pleiotropic Action of Renal Cell Carcinoma-Dysregulated miRNAs on Hypoxia-Related Signaling Pathways." The American Journal of Pathology 180, no. 4 (April 2012): 1675–
  13. 13. Majid Shahana, Sharanjot Saini, Altaf A. Dar, Hiroshi Hirata, Varahram Shahryari, Yuichiro Tanaka, Soichiro Yamamura, et al. "MicroRNA-205 Inhibits Src-Mediated Oncogenic Pathways in Renal Cancer." Cancer Research 71, no. 7 (April 1, 2011): 2611-21.
  14. 14. Neal Calida S, Michael Z. Michael, Lesley H. Rawlings, Mark B. Van der Hoek, and Jonathan M. Gleadle. "The VHL-Dependent Regulation of microRNAs in Renal Cancer." BMC Medicine 8 (October 21, 2010): 64.
  15. 15. Redova Martina, Marek Svoboda, and Ondrej Slaby. "MicroRNAs and Their Target Gene Networks in Renal Cell Carcinoma." Biochemical and Biophysical Research Communications 405, no. 2 (February 11, 2011):
  16. 16. Song Tao, Xu Zhang, Chunyang Wang, Yiguang Wu, Wei Cai, Jiangping Gao, and Baofa Hong. "MiR-138 Suppresses Expression of Hypoxia-Inducible Factor 1α (HIF-1α) in Clear Cell Renal Cell Carcinoma 786-O Cells." Asian Pacific Journal of Cancer Prevention: APJCP 12, no. 5 (2011): 1307-11.
  17. 17. Ueno K, H Hirata, V Shahryari, Y Chen, M S Zaman, K Singh, Z L Tabatabai, Y Hinoda, and R Dahiya. "Tumour Suppressor microRNA-584 Directly Targets Oncogene Rock-1 and Decreases Invasion Ability in Human Clear Cell Renal Cell Carcinoma." British Journal of Cancer 104, no. 2 (January 18, 2011): 308-15.
  18. 18. Zhai Qingna, Liang Zhou, Chunjuan Zhao, Jun Wan, Zhendong Yu, Xin Guo, Jie Qin, Jing Chen, and Ruijing Lu. "Identification of miR-508-3p and miR-509-3p That Are Associated with Cell Invasion and Migration and Involved in the Apoptosis of Renal Cell Carcinoma." Biochemical and Biophysical Research Communications 419, no. 4 (March 23, 2012): 621-26.
  19. 19. Zhang Aimin, Yi Liu, Yizhen Shen, Youhe Xu, and Xiangtie Li. "miR-21 Modulates Cell Apoptosis by Targeting Multiple Genes in Renal Cell Carcinoma." Urology 78, no. 2 (August 2011): 474.e13-474.e19.

Програмування -